An underground market for unlicensed slimming drugs is being driven by social media fitness personalities and sellers on messaging platforms, based on new investigations.
Experimental Treatment Gaining Popularity Online
Retatrutide, which is still in clinical trials, is being promoted by online personalities for its supposed fat-burning properties. Viewers are encouraged to contact these profiles directly for supplier links, while also obtaining promotional offers.
Active Commerce on Messaging Platforms
Separately, a flourishing trade exists on Telegram, where groups with thousands of members share “before and after” photos, administration instructions and claims of next-day British shipping. Sellers market the drug there before redirecting buyers to other platforms for transactions.
Learning About Retatrutide
This medication is an experimental injection created by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could assist patients lose up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being promoted digitally as the next Ozempic.
Medical Experts Express Concerns
However, doctors and pharmacists have cautions that the sale of what is still an unapproved medication in the UK is a cause for concern and could result in users administering substances of unknown origin.
Some experts stated the popularity for retatrutide could be linked to the increasing price of approved weight loss products such as Mounjaro.
Legal Position and Implementation
Selling retatrutide on TikTok or Telegram is illegal in the United Kingdom, as it is an unlicensed drug that must not be promoted or distributed for human use under the British medical regulations.
Some content creators try to circumvent the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and supply can still breach pharmaceutical, marketing, and consumer laws, potentially leading to fines, prosecution or prison.
Platform Reaction and Content Elimination
Based on the social media company, the platform has taken down problematic content and prohibited related hashtags and search suggestions. The organization stated it was dedicated to maintaining the service secure and investing in enhancing enforcement strategies.
Online Marketplace Operations
Investigations also discovered communities with up to nine thousand members marketing retatrutide using the platform's integrated search feature, which operates like a online catalog. Entering “retatrutide” immediately displays groups with thousands of users, filled with images of weight loss, glowing reviews and detailed instructions for mixing or administering at home.
After moments of joining one group, a vendor shared WhatsApp details, where the majority of purchases occur. The vendor sent an guidebook and guaranteed shipping within 48 hours. When asked whether the substance was genuine, one vendor responded: “You can’t be sure.” Another shared a photo of a supposed testing documentation. None asked about body mass, health issues or previous experience.
Item Details and Pricing
Inside these groups, posts display black plastic parcels with postal service labels, claiming to contain new batches. One communication stated: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, mixed at residence with sterile water, or ready-to-use injectors typically priced at £160 for 20 milligrams. When asked how much time a injector should be used, sellers give conflicting answers varying between a several days to “depends on your body”.
Service Oversight and Security Measures
A representative for the messaging service stated it regularly monitored harmful material on its service including content that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.
Medical Professional Warnings
“Individuals are injecting materials they can’t verify. Even if the science behind retatrutide is valid, these digital products may not contain what they claim,” said Jason Murphy, the head of pharmaceutical services at a pharmacy service.
Dr Crystal Wyllie of an online medical service linked the surge in demand to recent cost increases for approved slimming drugs such as Mounjaro. “With prices increasing, individuals are turning to online platforms. But fake injections are highly dangerous. You cannot know what’s inside or whether the environment they were produced in was clean,” she explained.
Her team has previously encountered patients injured by personal administration from unconfirmed suppliers. “We understand the frustration, but purchasing from messaging apps or communication platforms is taking chances with your health,” stated Wyllie. “These substances could be impure or improperly measured.”
Manufacturer Statement
A representative from Eli Lilly said retatrutide was in phase 3 clinical trials and had not been reviewed or approved by any regulatory agency globally. “Therefore at this point no one can market [it] for human use,” they explained, noting that any product “misleadingly claiming itself as a company investigational substance not yet authorized … may subject patients to possibly serious medical dangers”.
